| dc.description.referencetext | Alm, P. A. (2004). Stuttering and the basal ganglia circuits: A
critical review of possible relations. Journal of Communication
Disorders, 37, 325-369.
Bothe, A. K., Davidow, J. H., Bramlett, R. E., & Ingham, R. J.
(2006). Stuttering treatment research 1970-2005: I. Systematic
review incorporating trial quality assessment of behavioral,
cognitive, and related approaches. American Journal of Speech
Language Pathology, 15, 321-341.
Centre for Evidence-Based Medicine. (2006). Levels of evidence and
grades of recommendation. Retrieved September 10, 2007, from
http://www.cebm.net/index.asp
Chambless, D. L., & Hollon, S. D. (1998). Defining empirically
supported therapies. Journal of Consulting and Clinical Psychology,
66, 7-18.
Lavid, N., Franklin, D., & Maguire, G. (1999). Management of
child and adolescent stuttering with olanzapine: Three case
reports. Annals of Clinical Psychiatry, 11, 233-236.
Lickley, R. (2007). Some stuttering treatments are possibly
effective for some people, but more rigorous trials are required.
[Abstract]. Evidence-based Communication Assessment and
Intervention, 1, in press. Abstract of Bothe, A.,K., Davidow, J.
H., Bramlett, R. E., & Ingham (2006). American Journal of Speech
Language Pathology, 15, 321-341.
Maguire, G., Riley, G., Franklin, D., & Gottschalk, L. (2000).
Risperidone for the treatment of stuttering. Journal of Clinical
Psychopharmacology, 20, 479-482.
Maguire, G., Riley, G., Franklin, D., Maguire, M.,
Nguyen, C., & Brojeni, P. (2004). Olanzapine in the
treatment of developmental stuttering: A double-blind,
placebo-controlled trial. Annals of Clinical Psychiatry, 16,
63-67.
Riley, G., Maguire, G., Franklin, D., Ortiz, T., & Riley, J. (2001).
Effects of olanzapine on stuttering in adults. Paper presented at
the meeting of the American Speech-Language Hearing Association.
USA: New Orleans. | |
